Skip to main content

Table 5 Comparison of the therapeutic management between survivors and non-survivors

From: Factors associated with increased pancreatic enzymes in septic patients: a prospective study

Parameters

Survivors

(N = 30)

Non-survivors

(N = 20)

p

MV (N/%)

12/40

20/100

<0.001

Duration of MV (days [quartiles])

6 [2.3–18.8]

3.5 [2–12.5]

0.344

CRRT (N/%)

10/33.3

14/70

0.011

NE (N/%)

30/100

20/100

1

NE dose (mcg/kg/min [quartiles])

0.2 [0.09–0.42]

2 [0.7–2]

<0.001

  1. MV mechanical ventilation, CRRT continuous renal replacement therapy, NE norepinephrine